Wheeler Benjamin Richard bought MYGN
August 16, 2025 · Form 4 insider transaction
Wheeler Benjamin Richard bought 60,000 shares of Myriad Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
60,000
Price
$0.00
Total value
N/A
InsiderWheeler Benjamin Richard
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 16, 2025
Filing dateAugust 19, 2025
Shares owned after95,210
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.